17.0% of XBI Holdings Seeing Recent Insider Buys

A look at the weighted underlying holdings of the SPDR S&P Biotech ETF (XBI) shows an impressive 17.0% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying Merrimack Pharmaceuticals Inc.